Sjoerd Miedema

Sjoerd Miedema

Auto-generated profile, based on publicly available information

Sjoerd Miedema

Sofia University “St. Kliment Ohridski”, Sofia, Bulgaria

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2025 in Pharmacia
Verified
Journal Article
Open access
SMSjoerd Miedema
Sjoerd Miedema
DGDimitrina Georgieva
Dimitrina Georgieva
KNKremena Naydenova
Kremena Naydenova
VDVasil Dimitrov
Vasil Dimitrov
Tsvetelina VelikovaTsvetelina Velikova
Tsvetelina Velikova
The research presented in this article determined the systemic (blood plasma) and local (nasal lavage fluid) levels of interleukin-17 (IL-17) and interleukin-33 (IL-33) in healthy volunteers, patients with allergic rhinitis (AR), and patients with both allergic rhinitis and recently diagnosed bronchial asthma (AR+BA). IL-17 and IL-33 levels were consistent between AR and AR+BA patients but diverged when comparing either patient group or the combined group of all patients with healthy volunteers. These results indicate that AR and AR+BA patients represent a homogeneous group and suggest a role for IL-17 and/or IL-33 in the progression of AR to AR+BA. In conclusion, our data show that patients with AR only and those who progress to AR+BA from AR alone have elevated IL-17 levels in both nasal lavage fluid (NLF) and serum. This finding is consistent with recent studies and identifies a novel population of AR+BA patients with elevated IL-17 levels. The possibility of novel IL-33 regulatory mechanisms in these patients warrants further research.